Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 8, 1997, Pages 2423-2428

  Boot, Annemieke M ^a,c   Engels, Melanie A M J ^a   Boerma, Geert J M ^b   Krenning, Eric P ^c   De Muinck Keizer Schrama, Sabine M P F ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CALCITRIOL; CALCIUM; HUMAN GROWTH HORMONE; LIPID; PARATHYROID HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BODY COMPOSITION; BODY HEIGHT; BONE DENSITY; BONE MINERAL; CALCIUM BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; INFANT; LEAN BODY WEIGHT; LIPID METABOLISM; LUMBAR SPINE; MALE; OSSIFICATION; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROVOCATION TEST; SUBCUTANEOUS DRUG ADMINISTRATION; VOLUMETRY;

APOLIPOPROTEIN A-I; BODY COMPOSITION; BONE AND BONES; BONE DENSITY; CALCITRIOL; CALCIUM; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR I; LIPID METABOLISM; MALE; PARATHYROID HORMONE; SPINE;

EID: 0030788016     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.8.2423     Document Type: Article

References (50)

1. Degerblad M, Elgingy N, Hall K, Sjöberg HE, Thoren M. 1992 Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol (Copenh). 126:387-393.
2. Binnerts A, Swart GR, Wilson JHP, et al. 1992 The effect of GH administration in GH deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol (Oxf). 37:79-87.
3. Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ. 1980 Bone mineral status in growth hormone deficiency. J Pediatr. 96:393-396.
4. Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, DiNero G. 1993 Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr. 122:37-45.
5. Zamboni G, Antoniazzi F, Radetti G, Musumeci C, Tato L. 1991 Effects of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency. J Pediatr. 119:483-485.
6. Saggese G, Baroncelli GI, Bertelloni S, Barsanti S. 1996 The effect of long-term growth hormone treatment on bone mineral density in children with GH deficiency in the attainment of peak bone mass. J Clin Endocrinol Metab. 81:3077-3083.
7. Vandeweghe M, Taelman P, Kaufman JM. 1993 Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol (Oxf). 39:409-415.
8. Garry P, Collins P, Devlin JG. 1996 An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency. Eur J Endocrinol. 134:61-66.
9. Russel-Jones DL, Walts GF, Weissberger A, et al. 1994 The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Clin Endocrinol (Oxf). 41:345-350.
10. Johansson G, Oscarsson J, Rosen T, et al. 1995 Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone deficient adults. Arterioscler Thromb Vasc Biol. 15:2142-2150.
11. Kohno H, Ueyama N, Yanai S, Ukaji K, Honda S. 1994 Beneficial effect of growth hormone on atherogenic risk in children with growth hormone deficiency. J Pediatr. 126:953-955.
12. Schaefer GB, Greger NG, Fesmire JD, Blackett PR, Wilson DP, Frindik JP. 1994 Lipids and apolipoproteins in growth hormone deficient children during treatment. Metabolism. 43:1457-1461.
13. De Muinck Keizer-Schrama S, Rikken B, Hokken-Koelega A, Wit JM. 1994 Comparative study of two doses of growth hormone for growth hormone deficiency. Arch Dis Child. 71:12-18.
14. Roede MJ, van Wieringen JC. 1985 Growth diagrams 1980, Netherlands. Third nationwide survey. T Soc Gezondheidszorg. 63(S):1-34.
15. Hokken-Koelega ACS, Hackeng WHL, Stijnen T, Wit JM, de Muinck Keizer SMPF, Drop SLS. 1990 Twenty-four hour plasma growth hormone profiles, urinary GH excretion and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation. J Clin Endocrinol Metab. 71:688-695.
16. Tanner JM, Whitehouse R. 1976 Longitudinal standards for height, weight-height, weight-velocity and stages of puberty. Arch Dis Child. 51:170-179.
17. Weststrate JA, Deurenberg P, Van Tinteren H. 1989 Body fat distribution and adiposity indices in Dutch children 0-18 year age. Int J Obes. 13:465-477.
18. Johnson J, Dawson Hughes B. 1991 Precision and stability of dual energy x-ray absorptiometry measurements. Calcif Tissue Int. 49:174-178.
19. Kröger H, Vainio P, Nieminen J, Kotamieni A. 1995 Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology. Bone. 17:157-159.
20. Boot AM, de Ridder MAJ, Pols HAP, Krenning EP, de Muinck Keizer-Schrama SMPF. 1997 Bone mineral density in children and adolescents: relation to puberty, calcium intake and physical activity. J Clin Endocrinol Metab. 82:57-62.
21. Boot AM, Bouquet J, de Ridder MAJ, Krenning EP, de Muinck Keizer-Schrama SMPF. 1997 Determinants of body composition, measured by dual energy x-ray absorptiometry, in Dutch children and adolescents. Am J Clin Nutr. In press.
22. Tanner JM, Whitehouse RH, Cameron N, Marshall WA, Healy MJR, Goldstein H. 1983 Assessment of skeletal maturity and prediction of adult height (TW2 method). 2nd ed. London: Academic Press.
23. Kruse K, Kracht U. 1986 Evaluation of serum osteocalcin as an index of altered bone metabolism. Eur J Pediatr. 145:27-33.
24. Bluhmsohn A, Hannon RA, Wrate R, et al. 1994 Biochemical markers of bone turnover in girls during puberty. Clin Endocrinol (Oxf). 40:663-670.
25. Hertel NT, Stoltenberg M, Juul A, et al. 1993 Serum concentrations of Type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate. J Clin Endocrinol Metab. 76:924-927.
26. Knight D, Singer D, White JM, Fraser CG. 1988 Laboratory evaluation of the Du Pont "Dimension Clinical Chemistry System". Clin Chem. 34:1899-1903.
27. Boerma GJM, Jansen AP, Jansen RTP, Leijnse B, Van Strik R. 1996 Minimizing interlaboratory variation in routine assays of serum cholesterol by the use of serum calibrators. Clin Chem. 32:943-947.
28. Tiffany TO, Morton JM, Hall EM, Garrett AD. 1974 Clinical evaluation of kinetic enzymatic, fixed time and integral analysis of serum triglycerides. Clin Chem. 20:476.
29. Boerma GJM. 1987 Standardization of serum cholesterol and HDL-cholesterol measurements in the Netherlands: an overview. Tijdschr NVKC. 12:163-167.
30. Friedewald WT, Levy RI, Fredrickson DS. 1972 Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Clin Chem. 18:499-502.
31. Boerma GJM, De Bruijn AM, Van Teunenbroek A. 1994 Reference values for apolipoprotein A-1 and apolipoprotein B in serum depend on choice of assay techniques. Eur J Clin Chem Clin Biochem. 32:923-927.
32. Jeevanandam M, Hsu YC, Ramias L, Schiller WR. 1989 A rapid automated micromethod for measuring free fatty acids in plasma/serum. Clin Chem. 35:2228-2231.
33. Stiphout van WAHJ, Hofman A, Bruijn de AM, Valkenburg HA. 1985 Distributions and determinants of total and high-density lipoprotein cholesterol in Dutch children and young adults. Prev Med. 14:169-180.
34. Tietz NW. 1995 Clinical guide to laboratory tests. 3rd ed. Philadelphia: WB Saunders; ISBN 0-7216-5035-x.
35. Inzucchi SE, Robbins RJ. 1994 Effects of growth hormone on human bone biology. J Clin Endocrinol Metab. 79:691-694.
36. Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, DiNero G. 1994 Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal children and growth retarded children. Pediatr Res. 35:409-415.
37. Johansen JS, Jensen SB, Riis BJ, Rasmussen L, Zachman M, Christiansen C. 1990 Serum bone gla protein: a potential marker of growth hormone deficiency and the response to GH therapy. J Clin Endocrinol Metab. 71:122-126.
38. Kanzaki S, Hosoda K, Moriwake T, et al. 1992 Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone deficiency: a potential marker of bone growth and response to GH therapy. J Clin Endocrinol Metab. 75:1104-1109.
39. Trivedi P, Risteli J, Risteli L, Hindmarsh PC, Brook CGD, Mowat AP. 1991 Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatr Res. 30:276-280.
40. Calvo MS, Eyre DR, Gundberg CM. 1996 Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev. 17:333-368.
41. Dempster DW, Lindsay R. 1993 Pathogenesis of osteoporosis. Lancet. 341:797-805.
42. Ogle GD, Rosenberg AR, Calligeros D, Kainer G. 1994 Effects of growth hormone treatment for short stature on calcium homeostasis, bone mineralisation, and body composition. Horm Res. 41:16-20.
43. Vaisman N, Zadik Z, Shamai Y, Franklin L, Dukhan R. 1992 Changes in body composition of patients with subnormal spontaneous secretion of growth hormone, during the first year of treatment with growth hormone. Metabolism. 41:483-486.
44. Leger J, Carel C, Legrand I, Paulsen A, Hassan M, Czernichow P. 1994 Magnetic resonance imaging evaluation of adipose tissue and muscle tissue mass in children with growth hormone (GH) deficiency, Turner's syndrome, and intra-uterine growth retardation during the first year of treatment with GH. J Clin Endocrinol Metab. 78:904-909.
45. Harbison MD, Gertner JM. 1990 Permissive action of growth hormone on the renal response to dietary phosphorus deprivation. J Clin Endocrinol Metab. 70:1035-1040.
46. Fraser DR. 1995 Vitamin D. Lancet. 345:104-107.
47. Antoniazzi F, Radetti G, Zamboni G, Gambaro G, Adami S, Tato L. 1993 Effects of 1,25-dihydroxyvitamin D3 and growth hormone therapy on serum osteocalcin levels in children with growth hormone deficiency. Bone Miner. 21:151-156.
48. Takeuchi N, Matsumoto A, Katayama Y, et al. 1983 Changes with aging in serum lipoproteins and apolipoprotein C subclasses. Arch Gerontol Geriatr. 2:41-48.
49. Cuneo RC, Salomon F, Watts GF, Hesp R, Sönksen PH. 1983 Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism. 42:1519-1523.
50. Kannel WB, Wilson PWF. 1992 Efficacy of lipid profiles in prediction of coronary disease. Am Heart J. 124:768-774.